Morningstar

Vanguard Developed Markets Index Inv VDVIX

Morningstar Medalist Rating
Medalist Rating as of | See Vanguard Investment Hub
  • NAV / 1-Day Return 13.18  /  −0.75 %
  • Total Assets 204.3 Bil
  • Adj. Expense Ratio
    0.170%
  • Expense Ratio 0.170%
  • Distribution Fee Level Low
  • Share Class Type No Load
  • Category Foreign Large Blend
  • Investment Style Large Blend
  • Min. Initial Investment 0
  • Status Limited
  • TTM Yield 3.08%
  • Turnover 3%

USD | NAV as of Sep 27, 2024 | 1-Day Return as of Sep 27, 2024, 10:17 PM GMT+0

Morningstar’s Analysis VDVIX

Will VDVIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

  • Process Pillar

    The Process Pillar is our assessment of how sensible, clearly defined, and repeatable VDVIX’s performance objective and investment process is for both security selection and portfolio construction.

  • People Pillar

    The People Pillar is our evaluation of the VDVIX management team’s experience and ability. We find that high-quality management teams deliver superior performance relative to their benchmarks and/or peers.

  • Parent Pillar

    The Parent Pillar is our rating of VDVIX’s parent organization’s priorities and whether they’re in line with investors’ interests.

Comprehensive exposure to foreign developed markets.

Analyst Zachary Evens

Zachary Evens

Analyst

Summary

Vanguard FTSE Developed Markets Index has a market-cap-weighted portfolio that holds nearly all stocks in the developed international market. Its low fee and expansive portfolio make it one of the more appealing international stock funds available.

by Zachary Evens
Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings VDVIX

More VDVIX Holdings
  • Current Portfolio Date
  • Equity Holdings —
  • Bond Holdings —
  • Other Holdings —
  • % Assets in Top 10 Holdings 11.4
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Novo Nordisk AS Class B

1.75 3.6 Bil
Healthcare

ASML Holding NV

1.47 3.0 Bil
Technology

Nestle SA

1.16 2.4 Bil
Consumer Defensive

Samsung Electronics Co Ltd

1.09 2.2 Bil
Technology

AstraZeneca PLC

1.08 2.2 Bil
Healthcare

Novartis AG Registered Shares

1.02 2.1 Bil
Healthcare

SAP SE

0.99 2.0 Bil
Technology

Roche Holding AG

0.97 2.0 Bil
Healthcare

Shell PLC

0.94 1.9 Bil
Energy

Toyota Motor Corp

0.94 1.9 Bil
Consumer Cyclical

Sponsor Center